As biopharmaceutical pipelines expand with increasingly complex modalities at a faster rate than ever, the landscape for EHS leaders is rapidly evolving.

Navigating the complexities of compliance regulations while safeguarding your workforce has never been more critical. With an increasing number of R and D and manufacturing facilities across large pharma, biotech, CDMOs, and CROs, handling potentially hazardous chemical and biological materials, the demand for robust biosafety, ergonomic, chemical, and environmental protocols is at an all-time high.

You’ll have the unique chance to network with a focused group of EHS leaders from Genentech, Eli Lilly, Takeda and more as they share high-level strategies and practical, day-to-day solutions. You’ll be in the company of over 60 global directors, strategic leaders, and heads of EHS from the world’s largest pharmaceutical and biotech organizations, all converging to shape the future of EHS and S in the industry.

With a mix of breakout sessions, hands-on workshops, and in-depth discussions, learning from real-world case studies that cater to both large multinationals and smaller companies. This is your opportunity to discover how to streamline EHS and S practices, from regulatory compliance to corporate strategy and site-level implementation.

This winter, San Diego is the place to be if you’re serious about enhancing your EHS and S strategy, eliminating risk, and ensuring compliance across your global operations. Join us to equip yourself with the knowledge, connections, and tools needed to protect your workforce and lead your organization to a safer, more sustainable future.

URLs:
Website: https://go.evvnt.com/2598011-0?pid=11140
Brochure: https://go.evvnt.com/2598011-3?pid=11140

Prices:
Conference + 2 Workshops – Drug Developer Pricing: USD 3497.00,
Conference + 2 Workshops – Academic + Small Biotech Pricing: USD 2897.00,
Conference + 2 Workshops – Service Provider Pricing: USD 4297.00,
Conference + 1 Workshop – Drug Developer Pricing: USD 3048.00,
Conference + 1 Workshop – Academic + Small Biotech Pricing: USD 2548.00,
Conference + 1 Workshop – Service Provider Pricing: USD 3748.00,
Conference Only – Drug Developer Pricing: USD 2599.00,
Conference Only – Academic + Small Biotech Pricing: USD 2199.00,
Conference Only – Service Provider Pricing: USD 3199.00

Speakers: Allison Liljedahl Senior Manager, Program Biosafety Genentech, Andrea Mims Senior Director Health, Safety, Environmemtal Eli Lilly, Ann Marie Madera Senior Manager, Environmental Health and Safety Eikon Therapeutics, Blair Michael Head of Environmental, Health and Safety, Lonza Biologics Lonza, Cristina Cavalheiro Commercial and ITO Environment, Health and Safety Leader Cytiva, Edward David Associate Director Bristol Myers Squibb, Gary Ralph Director of Environmental Health and Safety SK Pharmateco, Joe Hess Senior Director, Environmental Health and Safety Gilead Sciences, Jordi Ramos Environmental Health and Safety Specialist PolyPeptide Group, Lynnette Cartagena Director, Research and Development ,Global Environmental Compliance and Sustainability Abbvie, Mike McCarthy Environmental Health Safety and Sustainability Senior Manager, Biosafety Officer Vertex Pharmaceuticals, Morgan Heyman US Head of Environment, Health, Safety and Sustainability PolyPeptide Group, Obed Varela Senior Director and Global Head Of Environmental Health and Safety, Plasma Derived Therapies Takeda, Paul Ryan Director, Environment, Occupational Health, Safety, and Sustainability, Research and Development Bristol Myers Squibb, Richard Silverman Principal Consultant BSI Group, Sara Hamel Senior Manager, Environmental, Health, Safety and Sustainability Kite Pharma, Steven Laflin Principal SHE Program Manager, Industrial Hygiene Genentech, Tom Evans Director, Facilities and Environmental Health and Safety Halozyme Therapeutics

Time: 9:00 am to 5:00 pm